In situ quasi-static and dynamic nanoindentation tests on calcified nodules formed by osteoblasts: Implication of glucocorticoids responsible for osteoblast calcification. (15th January 2015)

• Record Type: Journal Article
• Authors: Miyamoto, Sho; Miyamoto, Yoichi; Shibata, Yo; Yoshimura, Kentaro; Izumida, Eri; Suzuki, Hiroaki; Miyazaki, Takashi; Maki, Koutaro; Kamijo, Ryutaro
• Is Part Of: Acta biomaterialia. Volume 12(2015)
• Page Start: 216
• Page End: 226
• Publication Date: 2015-01-15
• Subjects: Nanoindentation -- Osteoblast -- Calcification -- Hydroxyapatite -- Hardness; Biomedical materials -- Periodicals; 610.28
• DOI: 10.1016/j.actbio.2014.10.038
• Languages: English
• ISSNs: 1742-7061

Abstract

Graphical abstract: Abstract: The functional requirements of regenerated calcified tissues are that they enable the tissues to bear a variety of imposed stress and consequent contact-induced strain without substantial fracture. Here we demonstrate the effects of glucocorticoid hormones such as dexamethasone and hydrocortisone on the nanomechanical properties of calcified nodules formed by mouse osteoblastic MC3T3-E1 cells in differentiation-inducing medium containing ascorbic acid and β-glycerophosphate. Neither cell proliferation nor calcium deposition, evaluated using alizarin red and von Kossa staining, was affected by dexamethasone. On the other hand, calcified nodules formed in the presence of dexamethasone were significantly harder and stiffer than those formed in their absence. In particular, a series of nanoindentation tests revealed that the calcified nodules formed in the presence of dexamethasone showed enhanced stiffness against dynamic strain as compared to a quasi-static load. Furthermore, Raman spectroscopy revealed that dexamethasone and hydrocortisone increased the apatite/matrix ratio and lowered that of carbonate in the nodules. Our results suggest that glucocorticoids are required for in vitro formation by osteoblasts of more mature calcified nodules containing apatite/phosphate.